Literature DB >> 27498975

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in South America.

Carlos Hernán Rodríguez1, Norah Balderrama Yarhui1, Marcela Nastro1, Tamara Nuñez Quezada2, Glenda Castro Cañarte3, Raquel Magne Ventura4, Tayita Ugarte Cuba5, Natalia Valenzuela6, Freddy Roach6, María Inés Mota7, Noelia Burger7, Gladys Velázquez Aguayo8, Juana Ortellado-Canese8, Geni Bruni9, Cecilia Pandolfo9, Nadya Bastyas9, Angela Famiglietti1.   

Abstract

One hundred and twenty-six epidemiologically sequential, unrelated, carbapenem-resistant Acinetobacter baumannii isolates from nine hospitals in six countries of South America were collected between July 2013 and June 2014. Genes coding for Ambler class D and B carbapenemases were sought by PCR. All isolates were typed using the 3-locus sequence typing and blaOXA-51-like sequence-based typing techniques. The blaOXA-23 gene was recovered in all the participating hospitals and in all the isolates of seven of nine medical centres. The blaOXA-72 gene was only recovered in the two medical centres from Guayaquil city, Ecuador. Trilocus sequence typing revealed the presence of sequence groups SG2, SG4 and SG5. blaOXA-51-like sequence-based typing revealed the presence of blaOXA-132, blaOXA-65, blaOXA-69 and blaOXA-64. Our results showed that the population of carbapenem-resistant A. baumannii in South America was principally associated with ST79, ST25 and ST15 (92 %) and harboured the blaOXA-23 gene mainly. CC2 was not detected.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27498975     DOI: 10.1099/jmm.0.000328

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

Review 1.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

2.  Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru.

Authors:  Saúl Levy-Blitchtein; Ignasi Roca; Stefany Plasencia-Rebata; William Vicente-Taboada; Jorge Velásquez-Pomar; Laura Muñoz; Javier Moreno-Morales; Maria J Pons; Juana Del Valle-Mendoza; Jordi Vila
Journal:  Emerg Microbes Infect       Date:  2018-07-04       Impact factor: 7.163

Review 3.  Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments.

Authors:  Emmanuel C Eze; Hafizah Y Chenia; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

4.  Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species.

Authors:  Inés Bado; Romina Papa-Ezdra; Jose F Delgado-Blas; Micaela Gaudio; Claudia Gutiérrez; Nicolás F Cordeiro; Virginia García-Fulgueiras; Lucía Araújo Pirez; Verónica Seija; Julio C Medina; Gloria Rieppi; Bruno Gonzalez-Zorn; Rafael Vignoli
Journal:  Microb Drug Resist       Date:  2018-06-19       Impact factor: 3.431

5.  Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Major Endemic Clones in South America.

Authors:  Carolina Silva Nodari; Rodrigo Cayô; Ana Paula Streling; Felipe Lei; Julia Wille; Myriam S Almeida; Alexandre Inacio de Paula; Antonio Carlos Campos Pignatari; Harald Seifert; Paul G Higgins; Ana Cristina Gales
Journal:  Front Microbiol       Date:  2020-11-30       Impact factor: 5.640

Review 6.  Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals.

Authors:  Susan Ibrahim; Nadal Al-Saryi; Israa M S Al-Kadmy; Sarah Naji Aziz
Journal:  Mol Biol Rep       Date:  2021-08-30       Impact factor: 2.316

7.  Pan-Resistome Insights into the Multidrug Resistance of Acinetobacter baumannii.

Authors:  Diego Lucas Neres Rodrigues; Francielly Morais-Rodrigues; Raquel Hurtado; Roselane Gonçalves Dos Santos; Daniela Camargos Costa; Debmalya Barh; Preetam Ghosh; Khalid J Alzahrani; Siomar Castro Soares; Rommel Ramos; Aristóteles Góes-Neto; Vasco Azevedo; Flávia Figueira Aburjaile
Journal:  Antibiotics (Basel)       Date:  2021-05-18

8.  Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan.

Authors:  Nabil Karah; Fizza Khalid; Sun Nyunt Wai; Bernt Eric Uhlin; Irfan Ahmad
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-01-15       Impact factor: 3.944

9.  Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings.

Authors:  Mariana Neri Lucas Kurihara; Romário Oliveira de Sales; Késia Esther da Silva; Wirlaine Glauce Maciel; Simone Simionatto
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581

10.  Diversity of carbapenem-resistant Acinetobacter baumannii and bacteriophage-mediated spread of the Oxa23 carbapenemase.

Authors:  Alaa Abouelfetouh; Jennifer Mattock; Dann Turner; Erica Li; Benjamin A Evans
Journal:  Microb Genom       Date:  2022-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.